Ping Capital Management Inc. Invests $237,000 in ARK Genomic Revolution ETF (BATS:ARKG)

Ping Capital Management Inc. bought a new position in shares of ARK Genomic Revolution ETF (BATS:ARKG) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 10,100 shares of the company’s stock, valued at approximately $237,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Principal Securities Inc. bought a new stake in ARK Genomic Revolution ETF in the fourth quarter valued at about $32,000. Chris Bulman Inc bought a new stake in ARK Genomic Revolution ETF in the second quarter valued at about $36,000. Tidemark LLC bought a new stake in ARK Genomic Revolution ETF in the fourth quarter valued at about $48,000. EverSource Wealth Advisors LLC bought a new stake in ARK Genomic Revolution ETF in the first quarter valued at about $49,000. Finally, Larson Financial Group LLC increased its holdings in ARK Genomic Revolution ETF by 4,576.1% in the second quarter. Larson Financial Group LLC now owns 3,320 shares of the company’s stock valued at $78,000 after purchasing an additional 3,249 shares during the last quarter.

ARK Genomic Revolution ETF Stock Down 2.9 %

BATS ARKG opened at $24.24 on Monday. The firm has a 50 day moving average of $25.38 and a 200-day moving average of $26.14.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.